Aspira Women's Health Inc.
AWH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $9,182 | $9,154 | $8,184 | $6,812 |
| % Growth | 0.3% | 11.9% | 20.1% | – |
| Cost of Goods Sold | $3,703 | $3,892 | $3,865 | $3,750 |
| Gross Profit | $5,479 | $5,262 | $4,319 | $3,062 |
| % Margin | 59.7% | 57.5% | 52.8% | 45% |
| R&D Expenses | $3,266 | $4,035 | $5,953 | $5,314 |
| G&A Expenses | $10,345 | $12,267 | $16,183 | $13,257 |
| SG&A Expenses | $18,491 | $20,079 | $31,131 | $30,343 |
| Sales & Mktg Exp. | $8,146 | $7,812 | $14,948 | $17,086 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $21,757 | $24,114 | $37,084 | $35,657 |
| Operating Income | -$16,278 | -$18,852 | -$31,138 | -$32,595 |
| % Margin | -177.3% | -205.9% | -380.5% | -478.5% |
| Other Income/Exp. Net | $3,184 | $2,162 | $1,253 | $933 |
| Pre-Tax Income | -$13,094 | -$16,690 | -$29,885 | -$31,662 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$13,094 | -$16,690 | -$29,885 | -$31,710 |
| % Margin | -142.6% | -182.3% | -365.2% | -465.5% |
| EPS | -0.93 | -1.81 | -3.85 | -4.28 |
| % Growth | 48.6% | 53% | 10% | – |
| EPS Diluted | -0.93 | -1.81 | -3.85 | -4.28 |
| Weighted Avg Shares Out | 14,135 | 9,233 | 8,060 | 7,414 |
| Weighted Avg Shares Out Dil | 14,135 | 9,233 | 8,060 | 7,414 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $48 | $17 | $0 |
| Interest Expense | -$33 | $0 | $0 | $48 |
| Depreciation & Amortization | $92 | $199 | $269 | $339 |
| EBITDA | -$16,186 | -$16,491 | -$30,874 | -$32,293 |
| % Margin | -176.3% | -180.2% | -377.2% | -474.1% |